A possible survival advantage in adults with acute leukemia receiving ABO‐identical platelet transfusions
- 1 February 1994
- journal article
- clinical trial
- Published by Wiley in American Journal of Hematology
- Vol. 45 (2), 189-190
- https://doi.org/10.1002/ajh.2830450219
Abstract
In a small cohort of leukemic patients participating in a randomized trial of ABO‐identical vs. ABO‐unmatched platelet transfusions, a statistically significant decrease in remission duration and increase in mortality were observed in patients receiving ABO‐unmatched platelet transfusions. This difference was unexplained by previously described prognostic factors for remission duration and survival. Further study of this association is warranted.Keywords
This publication has 5 references indexed in Scilit:
- The role of ABO matching in platelet transfusionEuropean Journal of Haematology, 1993
- Do white cells in stored blood components reduce the likelihood of posttransfusion bacterial sepsis?Transfusion, 1991
- Transfusion of ABO‐mismatched platelets leads to early platelet refractorinessBritish Journal of Haematology, 1990
- ABO INCOMPATIBILITY AND PLATELET TRANSFUSIONThe Lancet, 1990
- IMMUNE COMPLEXES SUPPRESS CELLULAR IMMUNITYAnnals of the New York Academy of Sciences, 1984